Core concepts in pharmacoepidemiology: confounding by indication and the role of active comparators

R Sendor, T Stürmer - Pharmacoepidemiology and drug safety, 2022 - Wiley Online Library
Confounding by indication poses a significant threat to the validity of nonexperimental
studies assessing effectiveness and safety of medical interventions. While no different from …

[HTML][HTML] Real-world evidence: the devil is in the detail

M Gokhale, T Stürmer, JB Buse - Diabetologia, 2020 - Springer
Much has been written about real-world evidence (RWE), a concept that offers an
understanding of the effects of healthcare interventions using routine clinical data. The …

[HTML][HTML] Buprenorphine versus methadone for opioid use disorder in pregnancy

EA Suarez, KF Huybrechts, L Straub… - … England Journal of …, 2022 - Mass Medical Soc
Background Opioid agonist therapy is strongly recommended for pregnant persons with
opioid use disorder. Buprenorphine may be associated with more favorable neonatal and …

Intermediate‐dose anticoagulation, aspirin, and in‐hospital mortality in COVID‐19: A propensity score‐matched analysis

ML Meizlish, G Goshua, Y Liu, R Fine… - American journal of …, 2021 - Wiley Online Library
Thrombotic complications occur at high rates in hospitalized patients with COVID‐19, yet the
impact of intensive antithrombotic therapy on mortality is uncertain. We examined in‐hospital …

Association of rivaroxaban vs apixaban with major ischemic or hemorrhagic events in patients with atrial fibrillation

WA Ray, CP Chung, CM Stein, W Smalley… - Jama, 2021 - jamanetwork.com
Importance The comparative effectiveness of rivaroxaban and apixaban, the most frequently
prescribed oral anticoagulants for ischemic stroke prevention in patients with atrial …

Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide …

TB Larsen, F Skjøth, PB Nielsen, JN Kjældgaard… - bmj, 2016 - bmj.com
Objective To study the effectiveness and safety of the non-vitamin K antagonist oral
anticoagulants (novel oral anticoagulants, NOACs) dabigatran, rivaroxaban, and apixaban …

Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care

Y Vinogradova, C Coupland, T Hill, J Hippisley-Cox - bmj, 2018 - bmj.com
Objective To investigate the associations between direct oral anticoagulants (DOACs) and
risks of bleeding, ischaemic stroke, venous thromboembolism, and all cause mortality …

Association between choice of radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance and patient-reported quality of life among men …

RC Chen, R Basak, AM Meyer, TM Kuo, WR Carpenter… - Jama, 2017 - jamanetwork.com
Importance Patients diagnosed with localized prostate cancer have to decide among
treatment strategies that may differ in their likelihood of adverse effects. Objective To …

Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide …

PB Nielsen, F Skjøth, M Søgaard, JN Kjældgaard… - bmj, 2017 - bmj.com
Objective To examine clinical effectiveness and safety of apixaban 2.5 mg, dabigatran 110
mg, and rivaroxaban 15 mg compared with warfarin among patients with atrial fibrillation …

Tenofovir is associated with lower risk of hepatocellular carcinoma than entecavir in patients with chronic HBV infection in China

TCF Yip, VWS Wong, HLY Chan, YK Tse, GCY Lui… - Gastroenterology, 2020 - Elsevier
Background & Aims There have been conflicting results from studies comparing the risk of
hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV) infection …